These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17164330)

  • 1. Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2.
    Chu PH; Huang TY; Williams J; Stafford DW
    Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19308-13. PubMed ID: 17164330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of a vitamin K epoxide reductase that catalyzes conversion of vitamin K 2,3-epoxide to 3-hydroxy-2-methyl-3-phytyl-2,3-dihydronaphthoquinone.
    Mukharji I; Silverman RB
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2713-7. PubMed ID: 3857611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The conversion of vitamin K epoxide to vitamin K quinone and vitamin K quinone to vitamin K hydroquinone uses the same active site cysteines.
    Jin DY; Tie JK; Stafford DW
    Biochemistry; 2007 Jun; 46(24):7279-83. PubMed ID: 17523679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and purification of the vitamin K1 2,3 epoxide reductases system from rat liver.
    Begent LA; Hill AP; Steventon GB; Hutt AJ; Pallister CJ; Cowell DC
    J Pharm Pharmacol; 2001 Apr; 53(4):481-6. PubMed ID: 11341364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of vitamin K epoxide reductase.
    Tie JK; Stafford DW
    Vitam Horm; 2008; 78():103-30. PubMed ID: 18374192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
    Wilson CR; Sauer JM; Carlson GP; Wallin R; Ward MP; Hooser SB
    Toxicology; 2003 Aug; 189(3):191-8. PubMed ID: 12832152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane.
    Cain D; Hutson SM; Wallin R
    J Biol Chem; 1997 Nov; 272(46):29068-75. PubMed ID: 9360981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel insight into the mechanism of the vitamin K oxidoreductase (VKOR): electron relay through Cys43 and Cys51 reduces VKOR to allow vitamin K reduction and facilitation of vitamin K-dependent protein carboxylation.
    Rishavy MA; Usubalieva A; Hallgren KW; Berkner KL
    J Biol Chem; 2011 Mar; 286(9):7267-78. PubMed ID: 20978134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of vitamin K epoxide to hydroxyvitamin K by liver microsomes from warfarin-resistant rats.
    Nutr Rev; 1983 Aug; 41(8):253-4. PubMed ID: 6355923
    [No Abstract]   [Full Text] [Related]  

  • 10. Membrane topology mapping of vitamin K epoxide reductase by in vitro translation/cotranslocation.
    Tie JK; Nicchitta C; von Heijne G; Stafford DW
    J Biol Chem; 2005 Apr; 280(16):16410-6. PubMed ID: 15716279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantum chemical study of the mechanism of action of Vitamin K epoxide reductase (VKOR) II. Transition states.
    Davis CH; Deerfield D; Wymore T; Stafford DW; Pedersen LG
    J Mol Graph Model; 2007 Sep; 26(2):401-8. PubMed ID: 17182266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.
    Rost S; Fregin A; Hünerberg M; Bevans CG; Müller CR; Oldenburg J
    Thromb Haemost; 2005 Oct; 94(4):780-6. PubMed ID: 16270630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural features determining the vitamin K epoxide reduction activity in the VKOR family of membrane oxidoreductases.
    Shen G; Li C; Cao Q; Megta AK; Li S; Gao M; Liu H; Shen Y; Chen Y; Yu H; Li S; Li W
    FEBS J; 2022 Aug; 289(15):4564-4579. PubMed ID: 35113495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of 3-hydroxy-2,3-dihydrovitamin K1 in vivo: relationship to vitamin K epoxide reductase and warfarin resistance.
    Preusch PC; Suttie JW
    J Nutr; 1984 May; 114(5):902-10. PubMed ID: 6726460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of hydroxyvitamin K by vitamin K epoxide reductase of warfarin-resistant rats.
    Fasco MJ; Preusch PC; Hildebrandt E; Suttie JW
    J Biol Chem; 1983 Apr; 258(7):4372-80. PubMed ID: 6833262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional study of the vitamin K cycle in mammalian cells.
    Tie JK; Jin DY; Straight DL; Stafford DW
    Blood; 2011 Mar; 117(10):2967-74. PubMed ID: 21239697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfide-dependent protein folding is linked to operation of the vitamin K cycle in the endoplasmic reticulum. A protein disulfide isomerase-VKORC1 redox enzyme complex appears to be responsible for vitamin K1 2,3-epoxide reduction.
    Wajih N; Hutson SM; Wallin R
    J Biol Chem; 2007 Jan; 282(4):2626-35. PubMed ID: 17124179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the gene for vitamin K epoxide reductase.
    Li T; Chang CY; Jin DY; Lin PJ; Khvorova A; Stafford DW
    Nature; 2004 Feb; 427(6974):541-4. PubMed ID: 14765195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase.
    Creedon KA; Suttie JW
    Thromb Res; 1986 Oct; 44(2):147-53. PubMed ID: 3787564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional insights into human vitamin K epoxide reductase and vitamin K epoxide reductase-like1.
    Van Horn WD
    Crit Rev Biochem Mol Biol; 2013; 48(4):357-72. PubMed ID: 23631591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.